Kristen Cunningham - 10 Sep 2026 Form 4 Insider Report for Lifevantage Corp (LFVN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Sep 2026, 18:55:59 UTC
Prior SEC filing
06 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kristen Cunningham

Key filing fact

Kristen Cunningham filed Form 4 for Lifevantage Corp (LFVN) on 14 Sep 2026.

Key facts

  • This page summarizes Kristen Cunningham's Form 4 filing for Lifevantage Corp (LFVN).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Sep 2026, 18:55.

Change

  • Previous filing in this sequence was filed on 06 Jul 2026.
  • Current net transaction value: -$55,649.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001938042 Primary reporting owner

Cunningham Kristen

Relationship
Chief Sales Officer
Address
3300 TRIUMPH BLVD, SUITE 700, LEHI
Signature
/s/ Kristen Cunningham
Signature date
14 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFVN transaction

Common Stock

Tax liability

Transaction value
Shares
-2,254
Change %
-1.7%
Price
$6.37*
Shares after
129,163
Date
10 Sep 2026
Ownership
Direct
LFVN transaction

Common Stock

Sale

Transaction value
$641
Shares
-100
Change %
-0.08%
Price
$6.41
Shares after
129,063
Date
11 Sep 2026
Ownership
Direct
LFVN transaction

Common Stock

Sale

Transaction value
$55,008
Shares
-8,901
Change %
-6.9%
Price
$6.18
Shares after
120,162
Date
14 Sep 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .